After our “Merger Monday”coverage two weeks ago, here is other M&A-related news outside our T&L industry and some more, hopefully useful, background:
> “AstraZeneca, Daiichi Sankyo in $6B oncology deal”
MarketWatch writes that:
“AstraZeneca PLC said Monday that it has entered into an oncology collaboration with Daiichi Sankyo Co. worth up to $6 billion that it said could redefine treatment standards in lung, breast and multiple other cancers.”
> “SAP to spin off its …
The post M&A radar: Deals, deals and then more deals – as gold breaks record highs appeared first on The Loadstar.
Source: The Loadstar